top of page

The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

FoodBev Media Logo
Nov - Food Bev - Website Banner - TIJ vs TTO 300x250.gif
Access more as a FoodBev subscriber

Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...

DSM-Firmenich has launched the sale of up to 6.7 million existing ordinary shares through an accelerated bookbuild offering of shares (Share Placement). The news follows the completion of the merger between DSM and Firmenich at the start of the month. The company has also raised total proceeds of €733 million following the sale of its ordinary shares to institutional investors, representing approximately 2.5% of DSM-Firmenich's share capital, at a price of €109.50 per share. The book was multiple times oversubscribed, indicating that investors were eager to buy the company’s shares. According to a statement, DSM-Firmenich intends to use the net proceeds of the Share Placement to "fund the cash consideration payable by the company in relation to the buy-out procedure in accordance with Dutch law that the company commenced in order to acquire the DSM ordinary shares that have not been tendered in the voluntary public exchange offer launched by the company for all the issued and outstanding DSM ordinary shares”. Closing and settlement of the Share Placement is expected to occur on 29 May 2023.

FoodBev Media

FoodBev Media

25 May 2023

DSM-Firmenich sells 6.7m ordinary shares through accelerated bookbuild

DSM-Firmenich sells 6.7m ordinary shares through accelerated bookbuild
Related posts
DSM-Firmenich proposes Richard Ridinger as new chairman as Thomas Leysen steps down

DSM-Firmenich proposes Richard Ridinger as new chairman as Thomas Leysen steps down

Cosaic secures $6m seed funding led by DSM-Firmenich Ventures

Cosaic secures $6m seed funding led by DSM-Firmenich Ventures

DSM-Firmenich invests $10m to modernise Schenectady premix hub in the US

DSM-Firmenich invests $10m to modernise Schenectady premix hub in the US

Vivici launches fermentation-derived lactoferrin, aiming to ease supply constraints

Vivici launches fermentation-derived lactoferrin, aiming to ease supply constraints

DSM-Firmenich to sell animal nutrition unit to CVC for €2.2bn, sharpens focus on food, health and beauty

DSM-Firmenich to sell animal nutrition unit to CVC for €2.2bn, sharpens focus on food, health and beauty

DSM-Firmenich opens new global food innovation centre in Delft, the Netherlands

DSM-Firmenich opens new global food innovation centre in Delft, the Netherlands

bottom of page